ALNAQ — Allena Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Allena Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	94.5	61.6	30	35	30
Prepaid Expenses
Total Current Assets	96	64.5	33	37.2	33
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.127	0.514	0.95	1.56	1.63
Other Long Term Assets
Total Assets	96.2	65.2	34.1	38.9	34.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	7.54	5.76	10.9	6.12	15.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	13.4	15.8	16.9	16.4	15.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	82.9	49.5	17.2	22.6	18.9
Total Liabilities & Shareholders' Equity	96.2	65.2	34.1	38.9	34.8
Total Common Shares Outstanding